Deepak Korgaonkar

Nifty Midcap 100, Smallcap 100 indices down nearly 1% in firm market

At 01:59 PM on Friday, the Nifty Midcap 100 and Nifty Smallcap 100 indices were down 0.6 per cent each, as against 0.7 per cent rise in the Nifty 50 index.

Nifty IT index up 12% in July; HCL Tech, TechM gain 20% from 52-week lows

However, despite recovery from lows, the Nifty IT index underperformed the market by falling 22 per cent, as against a 7.2 per cent decline in the Nifty 50 thus far in CY2026.

Reliance gains 2% ahead of Q1 results; should you buy, hold or sell?

Thus far in the calendar year 2026, RIL underperformed the market by falling 16 per cent, as compared to 8.7 per cent decline in the BSE Sensex.

BHEL hits all-time high; zooms 86% from April low on FPI buying, strong Q1

Analysts at ICICI Securities have a 'Buy' rating on BHEL stock with a fair value of ₹575 as they expect revenue and PAT to grow at a CAGR of 30.5 per cent and 90 per cent over FY26-FY28E.

Nifty Capital Market index slips over 2%; HDFC AMC, Groww down up to 5%

UTI AMC, Nuvama Wealth Management, 360 ONE WAM, KFin Technologies, Angel One and MCX dropped 3 per cent each in intra-day trade on Thursday.

Unimech Aerospace up 9%, hits 52-week high; Motilal Oswal initiates 'Buy'

Unimech Aerospace stock hit a 52-week high at ₹1,308, and has bounced back 88 per cent from its 52-week low of ₹695.05 hit on March 30, 2026.

ABB India soars 10%, hits 52-week high on strong earnings by parent company

Thus far in the calendar year 2026, ABB India has outperformed the market by surging 53 per cent, as compared to 9 per cent decline in the BSE Sensex.

Biocon gains 3%, stock nears record high; should you buy, hold or sell?

Biocon received approval from the European Medicines Agency (EMA) for a new drug product fill finish line for Semglee (insulin glargine) at its insulin manufacturing facility in Malaysia.

Emmvee Photovoltaic zooms 110% from March low; what's driving stock?

Share price of Emmvee Photovoltaic Power hit a new high of ₹371.45, surging 10% in Thursday's intra-day deals after reporting over 100% growth in Q1 net profit.

EMS stocks in demand; Dixon, Kaynes, Cyient DLM rally up to 7%; here's why

The Union Cabinet granted approvals to two key schemes: the Mobile Phone Manufacturing Scheme with an outlay of ₹62,500 crore, and ISM 2.0 with a budgeted outlay of ₹1.3 trillion.

Mukul Agrawal portfolio stock Hind Rectifiers zooms 19%, hits new high

According to the shareholding data, ace investor Mukul Agrawal held 1.45 equity stake in Hind Rectifiers as of March 2026.

Cement sector stocks log solid gains; Nuvoco Vistas up 26% in 2 days

Looking beyond the Q1, analysts expect domestic cement demand to grow at a healthy 6-8 per cent CAGR over FY27-FY29, driven by sustained public infra investments and housing demand.

Patanjali Foods tanks 15% on huge volumes; stock hits 6-year low

A combined 26.5 million equity shares representing 2.43 per cent of total equity of Patanjali Foods changed hands on the NSE and BSE till 11:12 AM on Wednesday.

Ather Energy surges 9%, market-cap crosses ₹50,000 crore; here's why

Hero MotoCorp's board at its meeting held on July 14, 2026 approved an additional investment of up to ₹1,000 crore in Ather Energy.

Landmark Cars zooms 35% in 2 days; what's driving auto dealer stock?

The average trading volumes at the Landmark Cars counter jumped over 10-fold, with a combined 5.6 million equity shares changing hands on the NSE and BSE till 09:29 AM on Wednesday.

Divi's Labs rallies 3%, market cap nears ₹2 trillion; what's driving stock?

As the largest pure-play API/CDMO, Divi's should continue benefiting from custom-synthesis order-book conversion and the structural China+1/BIOSECURE-linked tailwind, analysts believe.

Adani Group stocks up in weak market; Adani Power, Green Energy soar 6%

According to the June 2026 shareholding pattern, domestic mutual funds have increased their stake in four Adani Group stocks.

CarTrade zooms 70% since June, hits 6-month high; UBS sees more upside

UBS initiated coverage on CarTrade with a Buy rating and price target of ₹4,000, driven by significant top-line growth, as current revenue across its platforms represents only 3-4% of TAM.

Welspun Corp gains 4% in weak market, zooms 129% in 6 months; here's why

Welspun Corp announced receipt of fresh large orders worth ₹1,400 crore for supply of pipes for oil & gas export projects, from its India facility.

Biocon surges 6%, nears 52-week high after block deals; Mylan likely seller

According to reports, Mylan, which is part of Viatris, planned to sell up to 5.64 per cent stake in Biocon, worth up to ₹3,481 crore in block deals today.